Table 1 Baseline characteristics

Age*

44 ± 15

Caucasian, n (%)

37(88)

Male Gender, n (%)

27(64)

LVEF*

36 ± 15

RVEF*

44 ± 14

Maximum NC/C ratio*

3.6 ± 0.8

Number of NC segments*

5.9 ± 1.8

Initial NYHA Class, n (%)

I

2(5)

II

14(33)

III

24(57)

IV

2(5)

% of LGE*

13 ± 12

LVEDVI(ml/m²)*

131 ± 36

LV Mass Index(gm/m²)*

62 ± 29

Medication Use, n (%)

-β Blockers

33(79)

-ACE Inhibitors/ARBs

35(83)

-Loop Diuretics

21(50)

-Aldosterone Antagonists

16(38)

-Digoxin

10(24)